Oxytocin Effects on Cytokines and Endocrine Parameters After LPS Induced Systemic Inflammatory Effects in Healthy Volunteers
NCT00360048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2007-12-11
Summary
The aim of this study is to determine if oxytocin administration is able to blunt LPS induced increase of cytokines (TNF-α) and if there is a change in the endocrine response after lipopolysaccharide administration in humans.
Conditions
Interventions
- DRUG
-
oxytocin
Sponsors & Collaborators
-
Medical University of Vienna
lead OTHER
Principal Investigators
-
Martin Clodi, MD, Associate Professor · Medical University of Vienna
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-08-31
Countries
- Austria
Study Locations
More Related Trials
-
Vaccine Response in Patient With Sepsis
NCT04823039 ·Status: COMPLETED ·Phase: NA
-
The Distribution of Plasma Drug Concentrations of Beta-lactam Antibiotics in Intensive Care Unit Patients
NCT02446392 ·Status: COMPLETED
-
Effect of APC and Epo on the Inflammatory Response During Sepsis
NCT00229034 ·Status: COMPLETED
-
Pharmacokinetic of Ceftriaxone in Septic ICU Patients
NCT00449800 ·Status: UNKNOWN ·Phase: PHASE4
-
Cortisol Control of Human Inflammatory Responses to Endotoxin
NCT00396344 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Accuracy in Sepsis
NCT03956043 ·Status: COMPLETED
-
Use of Presepsin in the Emergency Department
NCT06150092 ·Status: RECRUITING
-
Glycocalyx and Microcirculation in Sepsis
NCT03960307 ·Status: COMPLETED
-
Usage of Procalcitonin to Reduce Antibiotics Duration in VAP in Neurosurgical ICU
NCT06395454 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Lactate Kinetics in Septic Shock
NCT05349370 ·Status: RECRUITING ·Phase: NA
-
Effects of Endotoxin in Normal Human Volunteers
NCT00001303 ·Status: COMPLETED ·Phase: PHASE1
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED
-
Hyperoxia and Hypertonic Saline in Septic Shock
NCT01722422 ·Status: TERMINATED ·Phase: NA
-
Adjunctive Sedation With Dexmedetomidine for the Prevention of Severe Inflammation and Septic Encephalopathy
NCT04076826 ·Status: COMPLETED ·Phase: NA
-
Development of Novel Non-invasive Inflammometry Following Lipopolysaccharide, Endotoxin (LPS) Challenge in Healthy Volunteers
NCT03044327 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Exhaled Breath Condensates of Septic Patients to Predict Development of Multi-organ Dysfunction Syndrome
NCT01503684 ·Status: UNKNOWN
-
The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients
NCT02306239 ·Status: UNKNOWN ·Phase: NA
-
Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock
NCT03014063 ·Status: COMPLETED
-
Trial of Hyperoxic O2 Therapy vs. Normoxic O2 Therapy in Sepsis
NCT02378545 ·Status: COMPLETED ·Phase: PHASE4
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream Infections
NCT00870623 ·Status: COMPLETED
-
Cerebral Oxygenation in Septic Patients Using Vasopressors - the Conscious Study
NCT02237833 ·Status: TERMINATED
-
The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation
NCT01099566 ·Status: COMPLETED ·Phase: PHASE4
-
Hemodynamic Effects of Ketone Esters in Patients With Sepsis Induced Cardiomyopathy
NCT06952140 ·Status: NOT_YET_RECRUITING ·Phase: NA